About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Dr. Arnau Hervera, main researcher Clinical Neuroimmunology, Vall Hebron Institut de Recerca (VHIR)
Abstract: Sensorimotor diseases including spinal cord injuries and multiple sclerosis, are diseases currently without a cure associated with severe chronic neurological disabilities, including pain or sensory and motor disabilities. Despite recent progress in our understanding of cellular and molecular mechanisms underlying some pathophysiological aspects of these diseases, there is still no medical intervention to cure them. The limited success of current therapies and treatments is highly associated with the lack of mechanistic insight in the pathophysiology of these diseases. Since the early days of my research career, I focused on understanding the cellular and molecular mechanisms underlying neural pathologies, from peripheral nerve and spinal cord injuries to autoimmune demyelinating diseases. In that context we identified a novel mechanism involving for the first time neuroimmune crosstalk leading to neuronal regeneration through redox signaling after peripheral injury. We also defined both the neuronal and inflammatory mechanisms that lead the inhibition of HDAC3 to induce axonal regeneration. We also characterized the mechanisms underlying neuronal activity modulation after axonal injury, by optogenetic and chemogenetic means.
Host; Dr. Carmen Espejo, main researcher Clinical Neuroimmunology, Vall Hebron Institut de Recerca. Senior researcher at the Vall d'Hebron Research Institute since 2014. I develop my research activity in the Clinical Neuroimmunology group – Center d'Esclerosi Múltiple de Catalunya and my main scientific interest is the study of the pathogenesis of multiple sclerosis with the aim to develop new therapeutic strategies.
Register here to attend by Zoom: https://gencat.zoom.us/j/92053839650